JPMorgan Chase & Co’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.4M Buy
480,276
+192,340
+67% +$9.79M ﹤0.01% 1606
2025
Q1
$13M Sell
287,936
-97,206
-25% -$4.38M ﹤0.01% 1999
2024
Q4
$15.9M Buy
385,142
+357,381
+1,287% +$14.8M ﹤0.01% 1898
2024
Q3
$1.08M Buy
27,761
+3,929
+16% +$153K ﹤0.01% 3606
2024
Q2
$815K Sell
23,832
-121,728
-84% -$4.16M ﹤0.01% 3610
2024
Q1
$3.66M Sell
145,560
-41,023
-22% -$1.03M ﹤0.01% 2761
2023
Q4
$5.51M Buy
186,583
+86,807
+87% +$2.56M ﹤0.01% 2492
2023
Q3
$3.15M Buy
99,776
+61,311
+159% +$1.94M ﹤0.01% 2716
2023
Q2
$995K Buy
38,465
+24,262
+171% +$628K ﹤0.01% 3445
2023
Q1
$341K Sell
14,203
-64,368
-82% -$1.55M ﹤0.01% 4024
2022
Q4
$1.53M Buy
78,571
+64,388
+454% +$1.26M ﹤0.01% 3124
2022
Q3
$299K Buy
14,183
+4,048
+40% +$85.3K ﹤0.01% 3995
2022
Q2
$197K Buy
10,135
+4,816
+91% +$93.6K ﹤0.01% 4331
2022
Q1
$117K Sell
5,319
-17,250
-76% -$379K ﹤0.01% 4669
2021
Q4
$360K Buy
22,569
+2,573
+13% +$41K ﹤0.01% 4232
2021
Q3
$399K Sell
19,996
-20,001
-50% -$399K ﹤0.01% 4079
2021
Q2
$691K Buy
39,997
+23,892
+148% +$413K ﹤0.01% 3830
2021
Q1
$319K Buy
16,105
+13,774
+591% +$273K ﹤0.01% 4269
2020
Q4
$41K Sell
2,331
-5,149
-69% -$90.6K ﹤0.01% 4491
2020
Q3
$145K Buy
7,480
+2,856
+62% +$55.4K ﹤0.01% 3888
2020
Q2
$90K Sell
4,624
-3,640
-44% -$70.8K ﹤0.01% 4002
2020
Q1
$116K Buy
8,264
+3,987
+93% +$56K ﹤0.01% 3897
2019
Q4
$105K Buy
4,277
+3,352
+362% +$82.3K ﹤0.01% 4001
2019
Q3
$9K Buy
+925
New +$9K ﹤0.01% 4584